RudaCure participated in the RESI (Redefining Early Stage Investments) Conference and was selected as 3rd place out of 70 companies in the Innovator's Pitch Challenge.
The RESI Conference, held in Boston from September 21–23, was attended by RudaCure — participating through the Shinhan Square Bridge program — along with approximately 70 other companies.
We would like to thank the Shinhan Square Bridge team in Korea for preparing the event,
and the KIC representatives we met through Boston meetings alongside this event, as well as OraTeam and NEMIC_Team for their valuable advice.
We are also grateful to THEA_Team and Santen_Team for their interest in RCI001 and the many ideas they shared. We will maintain this ongoing relationship to ensure a successful outcome for RCI001 clinical trials.
